PI
VRTX icon

PEAK6 Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

PEAK6 Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$38.7K Buy
83
+82
+8,200% +$39.4K ﹤0.01% 3144
2024
Q2 		$575 Sell
1
-1
-50% -$434 ﹤0.01% 3444
2024
Q1 		$993 Hold
2
– – ﹤0.01% 3849
2023
Q4 		$1.01K Sell
2
-2,647
-100% -$978K ﹤0.01% 4058
2023
Q3 		$921K Buy
2,649
+2,206
+498% +$772K ﹤0.01% 1906
2023
Q2 		$156K Buy
+443
New +$149K ﹤0.01% 3014
2023
Q1 		– Sell
-2,564
Closed -$769K – 5025
2022
Q4 		$740K Buy
2,564
+1,111
+76% +$339K ﹤0.01% 2186
2022
Q3 		$421K Buy
1,453
+1,008
+227% +$290K ﹤0.01% 3035
2022
Q2 		$157K Sell
445
-10,116
-96% -$2.71M ﹤0.01% 4939
2022
Q1 		$2.76M Sell
10,561
-1,254
-11% -$298K 0.01% 1579
2021
Q4 		$2.6M Sell
11,815
-23,374
-66% -$4.55M 0.01% 1644
2021
Q3 		$6.38M Buy
35,189
+35,183
+586,383% +$6.87M 0.01% 981
2021
Q2 		$1K Sell
6
-18,104
-100% -$3.79M ﹤0.01% 5018
2021
Q1 		$3.89M Sell
18,110
-34,234
-65% -$7.52M 0.01% 1257
2020
Q4 		$12.4M Buy
52,344
+48,508
+1,265% +$11.1M 0.03% 576
2020
Q3 		$1.04M Buy
+3,836
New +$1.06M ﹤0.01% 2230
2020
Q1 		– Sell
-7,406
Closed -$1.7M – 4587
2019
Q4 		$1.62M Sell
7,406
-35,915
-83% -$7.27M 0.01% 1235
2019
Q3 		$7.34M Buy
+43,321
New +$7.66M 0.05% 498
2019
Q2 		– Sell
-11,681
Closed -$2.04M – 4361
2019
Q1 		$2.15M Buy
+11,681
New +$2.16M 0.01% 1242

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PEAK6 Investments's VRTX Position: Q3 2024 in Review

PEAK6 Investments increased its Vertex Pharmaceuticals (VRTX) stake by 8,200% in Q3 2024, buying an estimated $39.4K and bringing the position to 83 shares worth $38.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3144.

PEAK6 Investments first reported a position in VRTX in Q1 2019 and has held it in 19 quarters since. The position peaked at $12.4M in Q4 2020. 1,544 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • PEAK6 Investments held 83 shares of Vertex Pharmaceuticals worth $38.7K as of Q3 2024.
  • PEAK6 Investments bought 82 Vertex Pharmaceuticals shares in Q3 2024, an estimated $39.4K.
  • Vertex Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3144 holding.
  • PEAK6 Investments first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 19 quarters since.
  • PEAK6 Investments's Vertex Pharmaceuticals position peaked at $12.4M in Q4 2020.
  • 1,544 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.